Applications of 2-(N-Morpholino)Ethanesulfonic Acid Potassium Salt in Industrial Manufacturing

2-(N-Morpholino)Ethanesulfonic Acid Potassium Salt delivers reliable pH stabilization and buffering in highly regulated industrial and scientific processes, meeting strict downstream requirements from bioprocessing to clinical diagnostics. As a leading manufacturer, we target precise application needs in demanding production environments. Below, we detail verified downstream segments, each tailored to real-world practice.

1. Biopharmaceutical Upstream Cell Culture Media

This additive provides stable pH control in both batch and fed-batch mammalian cell cultures, minimizing stress during protein expression and monoclonal antibody production. Major biomanufacturers select it for its low cytotoxicity and minimal interference with cell metabolism, ensuring consistent batch results and facilitating high-productivity fermentations.

Industry compliance standards

• USP General Chapter <1043> Ancillary Materials for Cell, Gene, and Tissue-Engineered Products
• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• ISO 13408-1: Aseptic Processing of Healthcare Products
• 21 CFR Parts 210/211 (US FDA cGMP for pharma production)

Typical usage ratio

• 5–50 mM, adjusted based on media composition and target cell line; lower end supports CHO cell lines, higher end for HEK and hybridoma cultures.

Downstream process integration

• Pre-mixed into dry or liquid basal media formulations before sterilization; added during upstream cell culture expansion or large-scale bioreactor inoculation.

Final product types

• Therapeutic monoclonal antibodies
• Recombinant proteins and enzymes
• Vaccine antigens
• Gene therapy viral vectors

2. In Vitro Diagnostic Buffer Systems

As a crucial buffering agent, our product ensures accurate and reproducible pH conditions in diagnostic reagent kits, particularly in immunoassay and molecular analysis workflows. Its consistent ionic strength and solubility suit automated dispensing and large-batch kit manufacturing, supporting precise clinical laboratory results required by medical device manufacturers.

Industry compliance standards

• ISO 13485: Quality Management for Medical Devices
• FDA 21 CFR 820 (Quality System Regulation for Medical Devices)
• IVD Directive 98/79/EC and IVDR (EU Reg. 2017/746)
• CLSI Guideline EP05 for IVD Reagent Consistency

Typical usage ratio

• 10–100 mM, determined by specific assay sensitivity and endpoint detection method; concentration adjusted for fluorescence or colorimetric detection requirements.

Downstream process integration

• Dosed directly into lyophilized or liquid kit master mixes; filled as premade buffer components for high-throughput assembly lines of test cartridges and microplate wells.

Final product types

• Clinical immunoassay kits (ELISA, CLIA)
• qPCR and isothermal amplification test kits
• Point-of-care lateral flow devices
• Automated chemistry analyzer reagents

3. Protein Purification and Chromatography Buffers

Industry employs this compound for pH control in chromatography buffers, especially within ion-exchange and affinity purification setups. The substance maintains resolution and reproducibility throughout complex downstream processing, including automated fractionation and process-scale column operations in large-volume protein manufacturing facilities.

Industry compliance standards

• European Pharmacopoeia (Ph. Eur.) 2.2.44 Chromatography
• USP General Chapter <621> Chromatography
• ICH Q6B: Specifications for Biotechnological/Biological Products
• ISO 9001:2015 (Production of Laboratory Reagents)

Typical usage ratio

• 10–50 mM for equilibration, washing, and elution steps; buffer strength customized to target protein isoelectric point and column loading.

Downstream process integration

• Prepared as buffer concentrates or ready-to-use solutions; introduced during pre-column equilibration and sustained throughout elution in automated protein purification skids.

Final product types

• Purified therapeutic proteins
• High-grade research proteins and enzymes
• Clinical-grade diagnostics production intermediates
• Pharmaceutical excipients subject to lab-scale and GMP batch production

4. Electrophoresis and Bioanalytical Reagent Formulations

This material stabilizes sample and running buffers for nucleic acid and protein electrophoresis, providing precise pH management crucial for resolution and migration consistency. As manufacturers automate analytical QC, they require batch-to-batch reproducibility and low absorbance background, both reliably achieved with this buffer in prepared gel systems.

Industry compliance standards

• OECD GLP (Good Laboratory Practice) for analytical method validation
• ISO/IEC 17025: Testing and Calibration Laboratories
• FDA 21 CFR Part 58 (GLP for Nonclinical Lab Studies)
• EP 2.2.31 Electrophoresis — European Pharmacopoeia

Typical usage ratio

• 20–50 mM for RNA/DNA gels, 25–40 mM for protein PAGE buffers; concentration varies based on buffer system and expected sample load.

Downstream process integration

• Incorporated into stock buffer concentrates for automatic gel preparation equipment; filled into pre-cast gel cassette fill lines and loading buffers for QC and production batch release testing.

Final product types

• Ready-to-use precast gels for capillary or slab electrophoresis
• Bioanalytical buffer kits for R&D and clinical trial QC
• Genomics and proteomics screening reagents
• GMP-compliant analytical controls for pharmaceutical release testing

5. Laboratory-Grade PCR and Molecular Biology Master Mixes

Manufacturing facilities incorporate this buffer into PCR and qPCR master mixes to support enzyme stability and reaction specificity. The consistent pH and ionic buffering allow high batch reproducibility for molecular biology tool suppliers serving pharmaceutical and academic markets, with formulations developed for lyophilized and liquid mix options.

Industry compliance standards

• IVD ISO 13485:2016 for Diagnostic Assay Components
• EU Regulation (IVDR) 2017/746 for diagnostic reagents
• ISO 9001:2015 for laboratory products
• OECD GLP for validation studies

Typical usage ratio

• 10–30 mM in master mix; precise content optimized for target Taq polymerase and assay chemistry, with further fine-tuning for multiplex applications.

Downstream process integration

• Added to pre-formulated enzyme and primer mixes during blending; dosed for bulk and small batch filling during kit assembly, compatible with freeze-drying and ambient liquid packaging lines.

Final product types

• PCR and qPCR assay master mixes
• Chemical-grade nucleic acid amplification kits
• Stabilized enzyme reagent blends for research and diagnostic use
• Ready-to-use nucleic acid extraction reagents